查找临床试验
已按「高胆固醇血症」检索，对应国际通用词 hypercholesterolemia
共找到 17 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 23:03，每 5 分钟自动同步A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
China
年龄 18 Years – 不限
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia
China
年龄 18 Years – 不限
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Child-Parent Familial Hypercholesterolemia Screening
China
年龄 1 Year – 3 Years
Children's Hospital of Fudan University
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Australia、China、India、Japan、Malaysia 等 9 国
年龄 18 Years – 不限
Stephen Nicholls
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
United States、Austria、China、Germany、Greece 等 11 国
年龄 2 Years – 11 Years
Novartis Pharmaceuticals
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
United States、Argentina、Brazil、Canada、Czechia 等 12 国
年龄 2 Years – 100 Years
Novartis Pharmaceuticals
A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia
Brazil、Hong Kong、Thailand
年龄 18 Years – 不限
Daiichi Sankyo
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
United States、Australia、Belgium、Brazil、Chile 等 12 国
年龄 6 Years – 17 Years
Merck Sharp & Dohme LLC
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
United States、Argentina、Austria、Belgium、Brazil 等 12 国
年龄 6 Years – 11 Years
Novartis Pharmaceuticals
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
China
年龄 12 Years – 55 Years
First Affiliated Hospital Xi'an Jiaotong University
CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
China
年龄 40 Years – 75 Years
West China Hospital
A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
China
年龄 18 Years – 85 Years
Beijing Suncadia Pharmaceuticals Co., Ltd